J Rheum Dis.  2022 Apr;29(2):75-78. 10.4078/jrd.2022.29.2.75.

The Korean College of Rheumatology: 40 Years of Public Health Influence

• Lee J
• Sung YK
• Lee MS
• Baek HJ

• KMID: 2527546
• DOI: http://doi.org/10.4078/jrd.2022.29.2.75

Figure

• 

  Fig. 1 A photo of the Korean College of Rheumatology Healing Camp with ankylosing spondylitis patients held on November 20~21, 2019, at Dam Yang, South Jeolla province, Korea.

Reference

1. Kim H, Cho SK, Kim JW, Jung SY, Jang EJ, Bae SC, et al. 2020; An increased disease burden of autoimmune inflammatory rheumatic diseases in Korea. Semin Arthritis Rheum. 50:526–33. DOI: 10.1016/j.semarthrit.2019.11.007. PMID: 31852583.

2. Seo MR, Kim G, Moon KW, Sung YK, Yoo JJ, Yoon CH, et al. 2021; Quality indicators for evaluating the health care of patients with rheumatoid arthritis: a Korean expert consensus. J Korean Med Sci. 36:e109. DOI: 10.3346/jkms.2021.36.e109. PMID: 33942576. PMCID: PMC8093604.

3. Cho SK, Kim D, Choi J, Lee S, Bae GE, Kim HK, et al. 2016; Impact of patient education on the satisfaction of rheumatoid arthritis patients: a randomized trial of nurse-led versus medical docter-led education. J Rheum Dis. 23:109–17. DOI: 10.4078/jrd.2016.23.2.109.

4. Paek SI, Jung SM, Lee J, Kwok SK, Kim WU, Park SH, et al. 2018; Effects of individual education using a treating-to-target strategy in patients with rheumatoid arthritis. J Rheum Dis. 25:255–62. DOI: 10.4078/jrd.2018.25.4.255.

5. Kim J, Koh JH, Choi SJ, Jeon CH, Kwok SK, Kim SK, et al. 2021; KOBIO, the first web-based Korean biologics registry operated with a unified platform among distinct disease entities. J Rheum Dis. 28:176–82. DOI: 10.4078/jrd.2021.28.4.176.

6. Kim SK, Choe JY, Lee SS, Shin K. 2017; Body mass index is related with the presence of syndesmophyte in axial spondyloarthritis: data from the Korean College of Rheumatology BIOlogics (KOBIO) registry. Mod Rheumatol. 27:855–61. DOI: 10.1080/14397595.2016.1265637. PMID: 27919202.

7. Kim SK, Kwak SG, Choe JY. 2020; Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: results from prospective nationwide KOBIO Registry. Medicine (Baltimore). 99:e19415. DOI: 10.1097/MD.0000000000019415. PMID: 32118795. PMCID: PMC7478791.

8. Kim SK, Choe JY, Kwak SG, Bae J, Park SH, Lee H. 2018; Effect of tumour necrosis factor-alpha inhibitors on renal function in patients with rheumatoid arthritis from the KOBIO registry from 2012 to 2016. Clin Exp Rheumatol. 36:1022–30.

9. Min HK, Kim HR, Lee SH, Shin K, Kim HA, Park SH, et al. 2021; Four-year follow-up of atherogenicity in rheumatoid arthritis patients: from the nationwide Korean College of Rheumatology Biologics Registry. Clin Rheumatol. 40:3105–13. DOI: 10.1007/s10067-021-05613-x. PMID: 33576925.

10. Kim Y, Park S, Kim HS. 2018; The effect of extra-articular manifestations on tumor necrosis factor-α inhibitor treatment duration in patients with ankylosing spondylitis: nationwide data from the Korean College of Rheumatology BIOlogics (KOBIO) registry. Clin Rheumatol. 37:3275–84. DOI: 10.1007/s10067-018-4290-0. PMID: 30251059.

11. Park DJ, Choi SJ, Shin K, Kim HA, Park YB, Kang SW, et al. 2017; Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy: results from the KOBIO registry. Clin Rheumatol. 36:1013–22. DOI: 10.1007/s10067-017-3584-y. PMID: 28243760.

12. Min HK, Kim HR, Lee SH, Hong YS, Kim MY, Park SH, et al. 2021; Retention rate and effectiveness of secukinumab vs TNF inhibitor in ankylosing spondylitis patients with prior TNF inhibitor exposure. Rheumatology (Oxford). 60:5743–52. DOI: 10.1093/rheumatology/keab245. PMID: 33725088.

13. Jung SM, Lee SW, Song JJ, Park SH, Park YB. 2020; Dec. 14. Drug survival of biologic therapy in elderly patients with rheumatoid arthritis compared with nonelderly patients: results from the Korean College of Rheumatology Biologics registry. J Clin Rheumatol. [Epub]. DOI: 10.1097/RHU.0000000000001644. PMID: 33337811.

14. Jung SM, Kwok SK, Ju JH, Lee SW, Song JJ, Yoon CH, et al. 2018; Risk factors associated with inadequate control of disease activity in elderly patients with rheumatoid arthritis: results from a nationwide KOrean College of Rheumatology BIOlogics (KOBIO) registry. PLoS One. 13:e0205651. DOI: 10.1371/journal.pone.0205651. PMID: 30325962. PMCID: PMC6191131.

15. Koh JH, Lee SK, Kim J, Kim HA, Shin K, Min JK. 2021; Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: real-world data from the KOBIO Registry. Clin Exp Rheumatol. 39:269–78.

16. Kim HA, Lee E, Lee SK, Park YB, Lee YN, Kang HJ, et al. 2020; Retention rate and safety of biosimilar CT-P13 in rheumatoid arthritis: data from the Korean College of Rheumatology Biologics registry. BioDrugs. 34:89–98. DOI: 10.1007/s40259-019-00393-y. PMID: 31734899. PMCID: PMC6985057.

17. Kim HA, Lee E, Lee SK, Park YB, Lee YN, Kang HJ, et al. 2020; Retention rate and long-term safety of biosimilar CT-P13 in patients with ankylosing spondylitis: data from the Korean College of Rheumatology Biologics registry. Clin Exp Rheumatol. 38:267–74.

18. Kim HA, Lee E, Lee SK, Park YB, Shin K. 2020; Retention rate and efficacy of the biosimilar CT-P13 versus reference infliximab in patients with ankylosing spondylitis: a propensity score-matched analysis from the Korean College of Rheumatology Biologics Registry. BioDrugs. 34:529–39. DOI: 10.1007/s40259-020-00432-z. PMID: 32696266. PMCID: PMC7391390.

19. Park EJ, Kim H, Jung SM, Sung YK, Baek HJ, Lee J. 2020; The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus. Korean J Intern Med. 35:41–59. DOI: 10.3904/kjim.2019.411. PMID: 31935319. PMCID: PMC6960050.

20. Park SY, Gong HS, Kim KM, Kim D, Kim HY, Jeon CH, et al. 2018; Korean guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. J Bone Metab. 25:195–211. DOI: 10.11005/jbm.2018.25.4.195. PMID: 30574464. PMCID: PMC6288607.

21. Seo YB, Moon SJ, Jeon CH, Song JY, Sung YK, Jeong SJ, et al. 2020; The practice guideline for vaccinating Korean patients with autoimmune inflammatory rheumatic disease. Infect Chemother. 52:252–80. DOI: 10.3947/ic.2020.52.2.252. PMID: 32618150. PMCID: PMC7335656.

22. Kim HS, Lee MS, Kim H, Sung YK, Lee J, Shim SC, et al. 2020; Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic. Rheumatol Int. 40:1347–9. DOI: 10.1007/s00296-020-04614-4. PMID: 32488428. PMCID: PMC7266385.

23. Seo MR, Kim JW, Park EJ, Jung SM, Sung YK, Kim H, et al. Korean College of Rheumatology working group. 2020; Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic. Korean J Intern Med. 35:1317–32. DOI: 10.3904/kjim.2020.417. PMID: 32972125. PMCID: PMC7652644.

24. Park JK, Lee EB, Shin K, Sung YK, Kim TH, Kwon SR, et al. Korean College of Rheumatology Task Force for COVID-19 Vaccine Guidance for Patients with Autoimmune Inflammatory Rheumatic Diseases. 2021; COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: clinical guidance of the Korean College of Rheumatology. J Korean Med Sci. 36:e95. DOI: 10.3346/jkms.2021.36.e95. PMID: 33783147. PMCID: PMC8007420.